Molecular Nutrition & Food Research · 2018 · 31 citations · 40 references
PharmacyPharmacokineticsPharmacologyBioavailabilityHuman NutritionMass Spectrometric AnalysisBioanalytical Method ValidationFood Effects On Oral AbsorptionAssayAssay SensitivityBioactive Compound AssessmentBiomarker Assay SensitivityHuman Health EffectsLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisSecondary Metabolites
Scope Curcumin (from turmeric), has been extensively investigated for potential beneficial properties in numerous diseases. Most work has focused on supra‐dietary concentrations/doses that would necessitate curcumin supplementation. However, much evidence instigating curcumin research is underpinned by epidemiological data based on low dietary intake via turmeric consumption. Methods and results Here, a novel, highly sensitive liquid chromatography–electrospray ionization–mass spectrometry (LC‐ESI‐MS/MS) method for detection of curcuminoids is described. Assay sensitivity is demonstrated in a pilot pharmacokinetic volunteer study following ingestion of foodstuffs containing a standardized mass of turmeric, representative of daily consumption by certain South Asian populations. Free parent curcumin was detectable in plasma from one individual, reaching maximal plasma concentrations ( C max ) of 3.2 n m . Curcumin conjugates were detected in all volunteers; C max for curcumin glucuronide is 47.6 ± 28.5 n m 30 min post‐food, while C max for demethoxycurcumin glucuronide and curcumin sulfate is ≈2 n m . Curcumin and its major metabolites persist in plasma for at least 8 h. Conclusion Despite poor absorption and rapid conjugation, dietary intake of standard culinary turmeric within complex food matrices furnished human plasma with detectable levels of curcuminoids. Whether sustained low systemic concentrations of these non‐nutritive, biologically active, dietary components may have pharmacological activity for human health benefit, warrants further research.
40
Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers
Guido Shoba, David C. Joy, Thangam Joseph et al. · Planta Medica · 1998 · 1.9K citations
Dose escalation of a curcuminoid formulation
Christopher D. Lao, Mack T. Ruffin, Daniel P. Normolle et al. · BMC Complementary and Alternative Medicine · 2006 · 1.4K citations · Full text
Pharmacy, Pharmacology, Toxicology +13
Phase I Clinical Trial of Oral Curcumin
Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · Clinical Cancer Research · 2004 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +13
Ricky A. Sharma, Heather R. McLelland, K A Hill et al. · PubMed · 2001 · 829 citations
Medicine, Oncology, Pharmacology +13